UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050550
Receipt number R000057433
Scientific Title Development of Feedback Sheet for Type 1 Diabetes Care - Derivation Study
Date of disclosure of the study information 2023/04/01
Last modified on 2024/01/26 00:14:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of Feedback Sheet for Type 1 Diabetes Care - Derivation Study

Acronym

T1DM FBS

Scientific Title

Development of Feedback Sheet for Type 1 Diabetes Care - Derivation Study

Scientific Title:Acronym

T1DM FBS

Region

Japan


Condition

Condition

Type 1 Diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Creation of a tool (feedback sheet) to continuously encourage patients with type 1 diabetes and their families to think and act on their own initiative to control their blood glucose.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

HbA1c change before and after feedback sheet use

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Use of feedback sheets

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 months-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Persons diagnosed with type 1 diabetes and on insulin therapy
Children or young adults under 40 years old
Patients who visit the hospital more than once in three month for treatment of type 1 diabetes mellitus
Persons who have been fully informed about the study and who have given their or their surrogate's free and voluntary consent based on a thorough understanding of the study

Key exclusion criteria

Persons deemed unsuitable as subjects by the investigators

Target sample size

15


Research contact person

Name of lead principal investigator

1st name Shogo
Middle name
Last name Akahoshi

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Division of Endocrinology and Metabolism

Zip code

183-8561

Address

2-8-29 Musashidai, Fuchu, Tokyo

TEL

042-300-5111

Email

shiyougo_akahoshi@tmhp.jp


Public contact

Name of contact person

1st name Tomohiro
Middle name
Last name Nagata

Organization

Tokyo Metropolitan Children's Medical Center

Division name

Clinical Research Support Center

Zip code

183-8561

Address

2-8-29 Musashidai, Fuchu, Tokyo

TEL

042-300-5111

Homepage URL


Email

tomohiro_nagata@tmhp.jp


Sponsor or person

Institute

Tokyo Metropolitan Children's Medical Center

Institute

Department

Personal name



Funding Source

Organization

Tokyo Metropolitan Government

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Metropolitan Children's Medical Center Research Ethics Review Committee

Address

2-8-29 Musashidai, Fuchu, Tokyo

Tel

042-300-5111

Email

sn_crsc03@tmhp.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 03 Month 09 Day

Date of IRB

2023 Year 05 Month 08 Day

Anticipated trial start date

2023 Year 05 Month 08 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 03 Month 09 Day

Last modified on

2024 Year 01 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057433


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name